Eleusis
London
About Eleusis
Eleusis is a clinical stage life science company dedicated to unlocking the therapeutic potential of serotonin 2A receptor agonists, commonly referred to as psychedelics, through the mitigation and management of psychoactivity
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.7M
- Funding stage: M&A
- Last round: Series A (Oct 2020)
- Website: eleusisltd.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/eleusis-156704 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.